Skip to main content
. 2019 Apr 20;9(4):e026645. doi: 10.1136/bmjopen-2018-026645

Figure 3.

Figure 3

Potential NOAC underdosing in new users with AF. NOAC, non-vitamin K antagonist oral anticoagulant; AF, atrial fibrillation; ATE, arterial thromboembolic events.